Matter Venture Partners

Lumafield provides industrial computed tomography solutions for non-destructive testing and inspection in engineering environments. Its Neptune X-ray CT scanner enables detailed imaging to analyze internal structures and detect defects across materials. The Voyager software platform delivers cloud-based AI-powered analysis, automated inspections, and collaboration tools to support product development from design through manufacturing. Triton is a high-speed CT system designed for rapid scanning in high-volume manufacturing settings. The company serves industries including aerospace, automotive, electronics, and medical devices, helping to improve product quality and reliability through advanced imaging and analysis capabilities.

Founded in 2018, Path Robotics specializes in manufacturing autonomous welding robots that incorporate AI and machine learning. These robots automate repetitive tasks, enhancing precision and adaptability while increasing productivity for manufacturers.

LightForce Orthodontics designs and manufactures customized, 3D-printed orthodontic solutions. Its product family includes Cloud Brackets, a white ceramic polycrystalline alumina bracket system; LightTray, a 3D-printed indirect bonding jig; and TurboTrays, 3D-printed guides for bite correction. The company’s technology enables precise slot dimensions and contoured edges with mass customization based on patient anatomy, and it operates a digital platform that connects orthodontists and technicians to co-create treatment plans. On-demand manufacturing supports patient-specific treatment, aiming to improve clinical outcomes and treatment efficiency.

Biostate AI specializes in developing a comprehensive biotechnology data aggregation and analysis platform. This platform integrates diverse data sources such as clinical trial results, regulatory information, and scientific publications, providing tools for data visualization, trend analysis, and predictive insights. The company's solution enables researchers to assess drug development progress and make evidence-based decisions, ultimately benefiting human health.